
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.000 | 100.000 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.743 | 19.680 |
Price to Book | 4.794 | 3.883 |
Price to Sales | 2.438 | 2.233 |
Price to Cash Flow | 15.295 | 14.780 |
Dividend Yield | 1.596 | 1.493 |
5 Years Earnings Growth | 12.429 | 9.837 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 95.640 | 94.326 |
Industrials | 2.040 | 3.309 |
Basic Materials | 1.390 | 1.986 |
Consumer Defensive | 0.930 | 3.041 |
Number of long holdings: 44
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UnitedHealth | US91324P1021 | 10.36 | 305.65 | +1.11% | |
Roche Holding Participation | CH0012032048 | 6.97 | 260.30 | -0.27% | |
Novo Nordisk A/S Class B | DK0060534915 | 6.87 | - | - | |
Amgen | US0311621009 | 6.18 | 286.35 | +0.26% | |
Elevance Health | US0367521038 | 5.54 | 317.96 | +2.43% | |
Vertex | US92532F1003 | 5.01 | 389.88 | -0.55% | |
Pfizer | US7170811035 | 4.04 | 24.69 | +0.35% | |
GSK plc | GB00BN7SWP63 | 3.51 | 1,452.50 | -0.48% | |
Veeva Systems A | US9224751084 | 3.22 | 268.08 | -1.56% | |
Regeneron Pharma | US75886F1075 | 3.21 | 576.68 | -0.50% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Growth Portfolio A Acs | 8.51B | -25.83 | 11.14 | 14.09 | ||
Thematic Research Portfolio S1X Acs | 1.96B | 10.14 | 21.69 | 12.12 | ||
Intl Health Care Portfolio A Accs | 3.21B | 23.27 | 20.58 | 15.22 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review